117 related articles for article (PubMed ID: 11592634)
21. Pneumocystis carinii: an atypical fungal micro-organism.
Cailliez JC; Séguy N; Denis CM; Aliouat EM; Mazars E; Polonelli L; Camus D; Dei-Cas E
J Med Vet Mycol; 1996; 34(4):227-39. PubMed ID: 8873881
[TBL] [Abstract][Full Text] [Related]
22. The role of alveolar macrophages in Pneumocystis carinii degradation and clearance from the lung.
Limper AH; Hoyte JS; Standing JE
J Clin Invest; 1997 May; 99(9):2110-7. PubMed ID: 9151783
[TBL] [Abstract][Full Text] [Related]
23. Pneumocystis carinii factor responsible for reduced phagocytic activity in alveolar macrophages.
Lasbury ME; Lin PM; Tschang D; Durant PJ; Lee CH
J Eukaryot Microbiol; 2003; 50 Suppl():641-2. PubMed ID: 14736197
[No Abstract] [Full Text] [Related]
24. Steady-state effects of vitronectin and fibronectin on the binding, uptake, and degradation of Pneumocystis carinii in rat alveolar macrophages.
Hoyte JS; Standing JE; Limper AH
Inflammation; 1997 Jun; 21(3):335-45. PubMed ID: 9246575
[TBL] [Abstract][Full Text] [Related]
25. Vitronectin, fibronectin, and gp120 antibody enhance macrophage release of TNF-alpha in response to Pneumocystis carinii.
Neese LW; Standing JE; Olson EJ; Castro M; Limper AH
J Immunol; 1994 May; 152(9):4549-56. PubMed ID: 7512599
[TBL] [Abstract][Full Text] [Related]
26. Myeloid-derived suppressor cells impair alveolar macrophages through PD-1 receptor ligation during Pneumocystis pneumonia.
Lei GS; Zhang C; Lee CH
Infect Immun; 2015 Feb; 83(2):572-82. PubMed ID: 25404033
[TBL] [Abstract][Full Text] [Related]
27. Differential Macrophage Polarization from Pneumocystis in Immunocompetent and Immunosuppressed Hosts: Potential Adjunctive Therapy during Pneumonia.
Nandakumar V; Hebrink D; Jenson P; Kottom T; Limper AH
Infect Immun; 2017 Mar; 85(3):. PubMed ID: 27993972
[TBL] [Abstract][Full Text] [Related]
28. Granulocyte-macrophage colony-stimulating factor in the innate immune response to Pneumocystis carinii pneumonia in mice.
Paine R; Preston AM; Wilcoxen S; Jin H; Siu BB; Morris SB; Reed JA; Ross G; Whitsett JA; Beck JM
J Immunol; 2000 Mar; 164(5):2602-9. PubMed ID: 10679099
[TBL] [Abstract][Full Text] [Related]
29. Defective nitric oxide production by alveolar macrophages during Pneumocystis pneumonia.
Lasbury ME; Liao CP; Hage CA; Durant PJ; Tschang D; Wang SH; Zhang C; Lee CH
Am J Respir Cell Mol Biol; 2011 Apr; 44(4):540-7. PubMed ID: 20558778
[TBL] [Abstract][Full Text] [Related]
30. Pro-inflammatory cytokines in lung and blood during steroid-induced Pneumocystis carinii pneumonia in rats.
Perenboom RM; Beckers P; Van Der Meer JW; Van Schijndel AC; Oyen WJ; Corstens FH; Sauerwein RW
J Leukoc Biol; 1996 Dec; 60(6):710-5. PubMed ID: 8975872
[TBL] [Abstract][Full Text] [Related]
31. Alveolar response to experimental Pneumocystis carinii pneumonia in the rat.
Lanken PN; Minda M; Pietra GG; Fishman AP
Am J Pathol; 1980 Jun; 99(3):561-88. PubMed ID: 6966893
[TBL] [Abstract][Full Text] [Related]
32. [Study on inflammatory response and alteration of biochemical components in BALF from Pneumocystis carinii pneumonia].
Rong Z; He L; Qu J
Zhonghua Jie He He Hu Xi Za Zhi; 1999 Sep; 22(9):548-51. PubMed ID: 11776769
[TBL] [Abstract][Full Text] [Related]
33. Alveolar macrophage and glycoprotein responses to Pneumocystis carinii.
Limper AH
Semin Respir Infect; 1998 Dec; 13(4):339-47. PubMed ID: 9872631
[TBL] [Abstract][Full Text] [Related]
34. Influence of Pneumocystis carinii on nitrite production by rat alveolar macrophages.
Simonpoli AM; Rajagopalan-Levasseur P; Brun-Pascaud M; Bertrand G; Pocidalo MA; Girard PM
J Eukaryot Microbiol; 1996; 43(5):400-3. PubMed ID: 8822811
[TBL] [Abstract][Full Text] [Related]
35. Production and role of nitric oxide in the alveolar immune response to Pneumocystis carinii.
Lasbury ME; Tang X; Durant PJ; Bartlett MS; Smith JW; Lee CH
J Eukaryot Microbiol; 2001; Suppl():165S-166S. PubMed ID: 11906046
[No Abstract] [Full Text] [Related]
36. Collagenases and the serine proteinases elastase and cathepsin G in steroid-induced Pneumocystis carinii pneumonia.
Sukura A; Konttinen YT; Sepper R; Kaartinen L; Sorsa T; Lindberg LA
J Clin Microbiol; 1995 Apr; 33(4):829-34. PubMed ID: 7790446
[TBL] [Abstract][Full Text] [Related]
37. Regulation of surfactant phosphatidylcholine secretion from alveolar type II cells during Pneumocystis carinii pneumonia in the rat.
Rice WR; Singleton FM; Linke MJ; Walzer PD
J Clin Invest; 1993 Dec; 92(6):2778-82. PubMed ID: 8254031
[TBL] [Abstract][Full Text] [Related]
38. Immunopathogenesis of Pneumocystis carinii pneumonia.
Gigliotti F; Wright TW
Expert Rev Mol Med; 2005 Nov; 7(26):1-16. PubMed ID: 16842636
[TBL] [Abstract][Full Text] [Related]
39. An experimental trial of artemether in treatment of Pneumocystis carinii in immunosuppressed rats.
Chen YT; Ma L; Mei Q; Tang Y; Liao XG
Chin Med J (Engl); 1994 Sep; 107(9):673-7. PubMed ID: 7805459
[TBL] [Abstract][Full Text] [Related]
40. Alveolar macrophages in AIDS patients: increased spontaneous tumour necrosis factor-alpha production in Pneumocystis carinii pneumonia.
Krishnan VL; Meager A; Mitchell DM; Pinching AJ
Clin Exp Immunol; 1990 May; 80(2):156-60. PubMed ID: 2357841
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
